Riskpilot← Back to searchSign inGet full accessDR SCENT AB
ABActiveOrg 5592631682Storgatan 43Retail sale of motor vehicles · NACE 4781Est. 20200 employees
Revenue 2025
SEK -5
-100% vs 2024
EBITDA margin
5154420.0%
-1361% vs 2024
Equity ratio
47.6%
Financial strength
Net profit 2025
SEK -258K
-1353% vs 2024
| Revenue | SEK -5 | -100% |
| EBITDA | SEK -258K | -1361% |
| Net profit | SEK -258K | -1353% |
| Total assets | SEK 51K | -80% |
| Equity | SEK 24K | -10% |
| Employees | 0 | — |
Legal name
DR SCENT AB
Org number
5592631682
Legal form
Aktiebolag
NACE code
4781 · Retail sale of motor vehicles
Founded
10 juli 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall importera hyra och sälja doft maskiner och luftrenare.
Address
Storgatan 43
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 669 | 1 261 | 221 | 51 | 16 | −0 |
| Staff expenses | — | — | −0 | — | — | — |
| EBITDA | −115 | −90 | −355 | −153 | −18 | −258 |
| Depreciation & amort. | −59 | −59 | — | — | — | — |
| EBIT | −174 | −149 | −355 | −153 | −18 | −258 |
| Net financials | — | −7 | −0 | −0 | −0 | −0 |
| Profit before tax | −174 | −155 | −355 | −153 | −18 | −258 |
| Tax | −0 | −0 | — | — | — | — |
| Net profit | −174 | −155 | −355 | −153 | −18 | −258 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 563 | 554 | 370 | 347 | 263 | 51 |
| Equity | −149 | 16 | 25 | 25 | 27 | 24 |
| Long-term debt | 640 | 500 | 0 | — | — | — |
| Short-term debt | 71 | 38 | 345 | 322 | 236 | 27 |
| Total debt | 711 | 538 | 345 | 322 | 236 | 27 |
EBITDA margin
-25772100.0%
This company
15.8%
Market median
-163114657% vs market
20202025
Equity ratio
47.6%
This company
38.2%
Market median
+25% vs market
20202025
Return on equity
-1052.4%
This company
18.4%
Market median
-5820% vs market
20202025
Net profit margin
-25776300.0%
This company
8.1%
Market median
-318226026% vs market
20202025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202025
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20202025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-07-01 – 2020-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DR SCENT AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohammed Mazhr Safi | Board of Directors | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Mazhar Safi | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |